Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Early view

Page Path
HOME > Browse Articles > Early view
8 Early view
Filter
Filter
Article category
Keywords
Authors

JMD Scientific Statements and Guidelines in the Early View area have been typeset, copyedited, and reviewed by the writing group or author, but they have not appeared in a print or online issue of the journal. In some cases, the statement or guideline may be revised before it is eventually published in print and online.

Each manuscript published online ahead of print is citable, with the official publication date being the date of the manuscript's first online posting. JMD papers are assigned Digital Object Identifiers (DOIs), providing a persistent, permanent way to identify manuscripts published in the online environment.

Original Article
Efficacy and Safety of Taltirelin Hydrate in Patients With Ataxia Due to Spinocerebellar Degeneration
Jin Whan Cho, Jee-Young Lee, Han-Joon Kim, Joong-Seok Kim, Kun-Woo Park, Seong-Min Choi, Chul Hyoung Lyoo, Seong-Beom Koh
Received May 28, 2024  Accepted October 18, 2024  Published online October 21, 2024  
DOI: https://doi.org/10.14802/jmd.24127    [Epub ahead of print]
  • 624 View
  • 136 Download
AbstractAbstract PDFSupplementary Material
Objective
We conducted this study to assess the efficacy and safety of taltirelin hydrate (TH) in patients with ataxia due to spinocerebellar degeneration (SCD).
Methods
Patients were randomly assigned to either the taltirelin group (5 mg orally, twice daily) or the control group. The primary endpoint was the change in the Korean version of the Scale for the Assessment and Rating of Ataxia (K-SARA) score at 24 weeks. The secondary endpoints included changes in the K-SARA score at 4 and 12 weeks as well as the Clinical Global Impression Scale, the five-level version of the EuroQol five-dimensional questionnaire, the Tinetti balance test, and gait analysis at 4, 12, and 24 weeks.
Results
A total of 149 patients (hereditary:nonhereditary=86:63) were enrolled. There were significant differences in the change in the K-SARA score at 24 weeks from baseline between the taltirelin group and the control group (-0.51±2.79 versus 0.36±2.62, respectively; p=0.0321). For the K-SARA items, the taltirelin group had significantly lower “Stance” and “Speech disturbance” subscores than the control group (-0.04±0.89 versus 0.23±0.79 and -0.07±0.74 versus 0.18±0.67; p=0.0270 and 0.0130, respectively). However, there were no significant differences in changes in other secondary efficacy outcome measures at 24 weeks from baseline between the two treatment arms (p>0.05).
Conclusion
Clinicians might consider the use of TH in the treatment of patients with ataxia due to SCD.
Letters to the editor
Muscle Dystonia Manifesting as Unilateral Rectus Abdominis Hypertrophy and Abdominal Pain in Parkinson’s Disease: A Case Report
Chengjian Wu, Yanhui Meng, Ming Yang
Received November 14, 2024  Accepted December 10, 2024  Published online December 10, 2024  
DOI: https://doi.org/10.14802/jmd.24230    [Epub ahead of print]
  • 343 View
  • 30 Download
PDF
Complete Relief of Tardive Truncal Dystonia With a Low Dose of Levodopa/Carbidopa: A Case Report
Shinichi Matsumoto, Satoshi Goto
Received November 15, 2024  Accepted December 8, 2024  Published online December 9, 2024  
DOI: https://doi.org/10.14802/jmd.24231    [Epub ahead of print]
  • 334 View
  • 51 Download
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Sulpiride

    Reactions Weekly.2025; 2040(1): 919.     CrossRef
The Application of Deep Brain Stimulation in the Syndrome of Irreversible Lithium-Effectuated Neurotoxicity
Lina Okar, Peyton Murin, Anagha Prabhune, Richard Bucholz, Pratap Chand
Received October 10, 2024  Accepted November 30, 2024  Published online December 2, 2024  
DOI: https://doi.org/10.14802/jmd.24209    [Epub ahead of print]
  • 287 View
  • 46 Download
PDF
Clozapine-Induced Negative Myoclonus Leads to Recurrent Falls: A Case Report
Shiny Joy, Punith Saroja Bylappa, Divyani Garg, Ayush Agarwal, Achal Kumar Srivastava
Received October 9, 2024  Accepted October 30, 2024  Published online November 11, 2024  
DOI: https://doi.org/10.14802/jmd.24207    [Epub ahead of print]
  • 334 View
  • 103 Download
  • 1 Crossref
PDF

Citations

Citations to this article as recorded by  
  • Clozapine/escitalopram

    Reactions Weekly.2024; 2038(1): 92.     CrossRef
Myoclonic Epilepsy of Unverricht and Lundborg in a Filipino Woman
Kruzette Khloe L. Solijon, Sheina B. Magtuba, Noel Belonguel, Gerard Saranza
Received August 2, 2024  Accepted October 7, 2024  Published online October 7, 2024  
DOI: https://doi.org/10.14802/jmd.24172    [Epub ahead of print]
  • 435 View
  • 67 Download
PDF
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay Masquerading as Charcot-Marie-Tooth Disease: A Case Study and Literature Review of Korean Patients
Yongmoo Kim, Seungbok Lee, Jae So Cho, Jihoon G Yoon, Sheehyun Kim, Man Jin Kim, Jong Hee Chae, Manho Kim, Jangsup Moon
Received March 3, 2024  Accepted July 8, 2024  Published online July 9, 2024  
DOI: https://doi.org/10.14802/jmd.24054    [Epub ahead of print]
  • 878 View
  • 86 Download
PDF
Erratum
Evidence-Based Review on Symptomatic Management of Huntington’s Disease
Jung Hwan Shin, Hui-Jun Yang, Jong Hyun Ahn, Sungyang Jo, Seok Jong Chung, Jee-Young Lee, Hyun Sook Kim, Manho Kim
Published online December 2, 2024  
DOI: https://doi.org/10.14802/jmd.24140e    [Epub ahead of print]
Corrects: J Mov Disord 2024;17(4):369
  • 384 View
  • 67 Download
PDF

JMD : Journal of Movement Disorders Twitter
Close layer
TOP